Latest BRCA1 Stories
An international consortium of scientists has discovered new genetic variants in five regions of the genome that affect the risk of ovarian cancer in the general population.
New research uncovers a case of mistaken identity that may have a significant impact on future breast cancer prevention and treatment strategies.
Women at increased risk of breast and ovarian cancer because of inherited mutations of the BRCA1 or BRCA2 genes who had prophylactic mastectomy or salpingo-oophorectomy (removal of the fallopian tubes and ovaries) had an associated decreased risk of breast cancer and ovarian cancer.
A new study underscores the importance for women with a family history of breast or ovarian cancer to get genetic counseling and testing for the BRCA1 and BRCA2 genes that make them more likely to develop lethal breast or ovarian cancer.
A recent study underscores the importance of genetic counseling and testing for women with family history of breast or ovarian cancer.
LANSDALE, Pa., May 13 /PRNewswire/ -- A guide to BRCA1 and BRCA2 genetic testing has been released by Hayes, Inc.
Genome rearrangements in 24 breast cancers.
New findings may help explain why women who carry a mutated BRCA1 gene have greater rates of infertility as well as a greater risk for breast and ovarian cancer.
Westchester Medical Center Physician and Fertility Preservation Expert leads study examining the association of breast cancer genes, breast cancer and infertility VALHALLA, N.Y., Dec.
Women with mutations in either their BRCA1 or BRCA2 genes have a dramatically increased risk of developing breast or ovarian cancer.
- A political dynamiter.